Evaluation of Adherence to European Society of Cardiology Guidelines for Heart Failure Patients in Shahid Modarres Hospital
Open Access
- 18 December 2024
- journal article
- Published by Brieflands in International Journal of Cardiovascular Practice
- Vol. 9 (2)
Abstract
Background: The prevalence of heart failure (HF) presents a significant burden on global healthcare systems, accounting for approximately 1.2% of the total healthcare budget. Adherence to the European Society of Cardiology (ESC) guidelines is associated with improved clinical outcomes, fewer cardiovascular hospitalizations, and delayed rehospitalization. Objectives: Given the lack of studies on compliance with ESC guidelines for HF patients in Iranian hospitals, this study aimed to evaluate the compliance of HF treatment at Shahid Modarres Hospital with the ESC guidelines. Methods: This descriptive cross-sectional study was conducted on 97 patients with HF who were referred to Shahid Modarres Hospital, Tehran, in 2023. Patients were diagnosed based on their medical records and clinical evaluations by a cardiologist. Medications were reviewed for compliance with the ESC guidelines regarding drug category, type, and dosage. Results: The results showed that 42.3% of patients received treatment in compliance with the ESC guidelines, while 57.7% had non-compliance. The most common non-adherence was observed in the use of ACE/ARB, mineralocorticoid receptor antagonists (MRAs), and Empa/Dapa drug combinations. The study found that 57% of patients were already being treated at Modarres Hospital, and treatment compliance was higher among these patients (60%), compared to those who referred to the hospital for the first time (30%). Conclusions: Although the HF treatment compliance rate at Shahid Modarres Hospital is high, it still requires improvement. A thorough examination of the underlying reasons for non-adherence to HF medication guidelines is needed, with the goal of identifying and addressing potential barriers to optimal treatment.Keywords
This publication has 38 references indexed in Scilit:
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical PracticeJAMA Cardiology, 2020
- Physicians' Guideline Adherence is Associated with Long-Term Heart Failure Mortality in Outpatients with Heart Failure with Reduced Ejection Fraction: The Qualify International RegistryEuropean Journal of Heart Failure, 2019
- Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction SpectrumEuropean Journal of Heart Failure, 2018
- Eligibility of Sacubitril–Valsartan in a Real-World Heart Failure Population: A Community-Based Single-Centre StudyESC Heart Failure, 2018
- Epidemiology, Pathophysiology and Clinical Outcomes for Heart Failure Patients with a Mid-Range Ejection FractionEuropean Journal of Heart Failure, 2017
- Characterization of Heart Failure Patients with Mid-Range Left Ventricular Ejection Fraction—a Report from the CHART-2 StudyEuropean Journal of Heart Failure, 2017
- European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across RegionsEuropean Journal of Heart Failure, 2016
- A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010JAMA Internal Medicine, 2015
- Prevalence of Unrecognized Heart Failure in Older Persons with Shortness of Breath on ExertionEuropean Journal of Heart Failure, 2014
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of internal medicine (1960), 2002